Active Ingredient History
Vonoprazan, sold under the brand name Takecab among others, is a first-in-class potassium-competitive acid blocker medication. It was approved in the Japanese market in February 2015. Wikipedia
Combination drugs
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acute Coronary Syndrome (Phase 4)
Drugs, Investigational (Phase 1)
Duodenal Ulcer (Phase 3)
Esophagitis (Phase 4)
Esophagitis, Peptic (Phase 4)
Fasting (Phase 1)
Gastritis (Phase 4)
Gastroesophageal Reflux (Phase 4)
Healthy Volunteers (Phase 3)
Heartburn (Phase 2)
Helicobacter pylori (Phase 4)
Intestinal Neoplasms (Phase 2)
Peptic Ulcer (Phase 1)
Stomach Ulcer (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue